Targeting CD38 with isatuximab and a novel CD38/CD3xCD28 trispecific T-cell engager in older patients with acute myeloid leukemia

被引：2

作者：

Martin-Sanchez, Esperanza ^{[1
]}

Blanco, Laura ^{[1
]}

Kim, Peter S. ^{[2
]}

Bisht, Kamlesh ^{[2
]}

Wang, Hongfang ^{[2
]}

van de Velde, Helgi ^{[2
]}

Jelinek, Tomas ^{[1
,3
,4
]}

Simoes, Catia ^{[1
]}

Prosper, Felipe ^{[1
]}

Miguel, Jesus F. San ^{[1
]}

Alfonso, Ana ^{[1
]}

Bergua, Juan ^{[5
]}

Rodriguez-Veiga, Rebeca ^{[6
]}

Vives, Susana ^{[7
]}

Martinez-Cuadron, David ^{[6
,7
]}

Montesinos, Pau ^{[6
,7
]}

Paiva, Bruno ^{[1
]}

Zabaleta, Aintzane ^{[1
]}

机构：

[1] Clin Univ Navarra, Inst Invest Sanit Navarra, Ctr Invest Med Aplicada, Canc Ctr,CIBER ONC Numbers CB16 12 00369 & CB16 12, Pamplona, Spain

[2] Sanofi R&D, North Amer, Cambridge, MA USA

[3] Univ Ostrava, Univ Hosp Ostrava, Dept Hematooncol, Ostrava, Czech Republic

[4] Univ Ostrava, Fac Med, Ostrava, Czech Republic

[5] Hosp San Pedro Alcantara, Caceres, Spain

[6] Hosp Univ La Fe, Valencia, Spain

[7] Hosp Germans Trias I Pujol, Josep Carreras Res Inst, Inst Catala Oncol Badalona, Badalona, Spain

来源：

BLOOD ADVANCES | 2024年 / 8卷 / 15期

关键词：

OPEN-LABEL; DEXAMETHASONE; DARATUMUMAB; LENALIDOMIDE; EXPRESSION; TREAT;

D O I：

10.1182/bloodadvances.2024013212

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3875 / 3879

页数：5

共 50 条

[41] Inhibition of CD38 shows anti-leukemic Activity in the acute myeloid Leukemia
Farber, Meike
Arnold, Lucas
Chen, Yiyang
Moellmann, Michael
Carpinteiro, Alexander
Duehrsen, Ulrich
Hanoun, Maher
INTERNIST, 2019, 60 : S7 - S8
[42] CD38 knocKout natural killer cells expressing an affinity optimized CD38 chimeric antigen receptor successfully target acute myeloid leukemia with reduced effector cell fratricide
Gurney, Mark
Stikvoort, Arwen
Nolan, Emma
Kirkham-McCarthy, Lucy
Khoruzhenko, Stanislav
Shivakumar, Rama
Zweegman, Sonja
Van de Donk, Niels W. C. J.
Mutis, Tuna
Szegezdi, Eva
Sarkar, Subhashis
O'Dwyer, Michael
HAEMATOLOGICA, 2022, 107 (02) : 437 - 445
[43] CD34 and CD38 are prognostic biomarkers for acute B lymphoblastic leukemia
Jiang Z.
Wu D.
Lin S.
Li P.
Biomarker Research, 4 (1)
[44] CD38 Targeting Holds Potential for the Treatment of Aggressive Refractory Cutaneous T-Cell Lymphomas
Pavlova, Olesya
Tsai, Yi-Chien
Chang, Yun-Tsan
Eisenring, Maya Vonow
Guenova, Emmanuella
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (07) : 1122 - 1126
[45] Efficient Targeting of CD38 in Mature T-Cell Neoplasms with Daratumumab and Allogeneic NK Cells
Johnson, William T.
Isabelle, Colleen
Vogel, Ashley N.
Brammer, Jonathan E.
Boles, Amy E.
McConnell, Kathleen
Berge, Robyn
Nisenfeld, Liam
Uppal, Guldeep
Gong, Jerald
Chakravarti, Nitin
Porcu, Pierluigi
Mishra, Anjali
BLOOD, 2021, 138
[46] PROGNOSTIC VALUE OF T-CELL CD38 EXPRESSION IN B-CHRONIC LYMPHOCYTIC LEUKEMIA
Abousamra, N. K.
El-Din, M. S.
Azmy, E. A.
ANNALS OF ONCOLOGY, 2012, 23 : 22 - 22
[47] PROGNOSTIC VALUE OF T-CELL CD38 EXPRESSION IN B-CHRONIC LYMPHOCYTIC LEUKEMIA
Abousamra, Nashwa
El-Din, Manal Salah
Azmy, Emad
CYTOMETRY PART B-CLINICAL CYTOMETRY, 2011, 80B (06) : 414 - 414
[48] CD38: T Cell Immuno-Metabolic Modulator
Kar, Anwesha
Mehrotra, Shikhar
Chatterjee, Shilpak
CELLS, 2020, 9 (07) : 1 - 20
[49] Relationship between CD34/CD38 and side population (SP) defined leukemia stem cell compartments in acute myeloid leukemia
Moshaver, Bijan
Wouters, Rolf F.
Kelder, Angele
Ossenkoppele, Gert J.
Westra, Guus A. H.
Kwidama, Zinia
Mitten, Arjo R.
Kaspers, Gert J. L.
Zweegman, Sonja
Cloos, Jacqueline
Schuurhuis, Gerrit J.
LEUKEMIA RESEARCH, 2019, 81 : 27 - 34
[50] CD38 in T- and B-cell functions
Deterre, P
Berthelier, V
Bauvois, B
Dalloul, A
Schuber, F
Lund, F
HUMAN CD38 AND RELATED MOLECULES, 2000, 75 : 146 - 168

← 1 2 3 4 5 →